Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients

Journal of the American College of Cardiology

Volumn 49, Issue 22, 2007, Pages 2172-2181

  Shadman, Ramin ^a   Allison, Matthew A ^a   Criqui, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CAUSE OF DEATH; CIGARETTE SMOKING; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR DISEASES;

EID: 34249296323     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.02.047     Document Type: Article

References (42)

1. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
2. Criqui M.H., Coughlin S.S., and Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation 72 (1985) 768-773
3. Howell M.A., Colgan M.P., Seeger R.W., Ramsey D.E., and Sumner D.S. Relationship of severity of lower-limb peripheral vascular-disease to mortality and morbidity-a 6-year follow-up-study. J Vasc Surg 9 (1989) 691-697
4. Allison M.A., Ho E., Denenberg J.O., et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med 32 (2007) 328-333
5. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
6. Campbell D.J., Woodward M., Chalmers J.P., et al. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation 112 (2005) 110-116
7. Bhalla M.A., Chiang A., Epshteyn V.A., et al. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol 44 (2004) 1047-1052
8. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., and Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293 (2005) 1609-1616
9. Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
10. Mlekusch W., Exner M., Sabeti S., et al. Serum creatinine predicts mortality in patients with peripheral artery disease: influence of diabetes and hypertension. Atherosclerosis 175 (2004) 361-367
11. O'Hare A.M., Bertenthal D., Shlipak M.G., Sen S., and Chren M.-M. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 16 (2005) 514-519
12. Ueda R., Yokouchi M., Suzuki T., Otomo E., and Katagiri T. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med 114 (2003) 266-270
13. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
14. Heart Protection Study Collaborative Group. N-terminal pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF Heart Protection study. J Am Coll Cardiol 49 (2007) 311-319
15. Bibbins-Domingo K., Gupta R., Na B., Wu A.H.B., Schiller N.B., and Whooley M.A. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 297 (2007) 169-176
16. Fried L.P., Kronmal R.A., Newman A.B., et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health study. JAMA 279 (1998) 585-592
17. Sarnak M., and Levey A. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 35 (2000) S117-S131
18. Wannamethee S.G., Shaper A.G., and Perry I.J. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke 28 (1997) 557-563
19. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
20. Cases A., and Coll E. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int Suppl (2005) S87-S93
21. Tunuguntla A., and Yerra L. The renal patient with cardiovascular disease-no longer a simple plumbing problem. Tenn Med 98 (2005) 395-396 399
22. Blankenberg S., McQueen M.J., Smieja M., et al. Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation 114 (2006) 201-208
23. Tsutamoto T., Wada A., Sakai H., et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 47 (2006) 582-586
24. Luchner A., Hengstenberg C., Lowel H., Riegger G.A.J., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 (2005) 118-123
25. Bird C., Criqui M.H., Fronek A., et al. Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 4 (1999) 15-21
26. Sugiuchi H, Uji Y, Okabe H, et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. 1995;41:717-23.
27. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D., and Modification of Diet in Renal Disease study group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
28. Saleem M., Florkowski C.M., George P.M., and Woltersdorf W.W. Comparison of two prediction equations with radionuclide glomerular filtration rate: validation in routine use. Ann Clin Biochem 43 (2006) 309-313
29. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.-y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
31. Shlipak M.G., Simon J.A., Grady D., Lin F., Wenger N.K., and Furberg C.D. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38 (2001) 705-711
32. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42 (2003) 1050-1065
33. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study. Circulation 106 (2002) 416-422
34. Froissart M., Rossert J., Jacquot C., Paillard M., and Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16 (2005) 763-773
35. Anwaruddin S., Lloyd-Jones D.M., Baggish A., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Am Coll Cardiol 47 (2006) 91-97
36. Svensson P., de Faire U., Niklasson U., Hansson L.O., and Ostergren J. Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease. Blood Press 14 (2005) 99-106
37. Montagnana M., Lippi G., Fava C., et al. Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease. Clin Chem Lab Med 44 (2006) 207-212
38. Culleton B.F., Larson M.G., Wilson P.W., Evans J.C., Parfrey P.S., and Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56 (1999) 2214-2219
39. Garg A.X., Clark W.F., Haynes R.B., and House A.A. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 61 (2002) 1486-1494
40. Kasama S., Toyama T., Hatori T., et al. Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. Heart 92 (2006) 625-630
41. Wallen T., Landahl S., Hedner T., Nakao K., and Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart 77 (1997) 264-267
42. Rothenbacher D., Koenig W., and Brenner H. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med 166 (2006) 2455-2460